Survival after palliative radiation therapy for cancer : the METSSS model

Article

ZAORSKY, Nicholas G. | LIANG, Menglu | PATEL, Rutu | LIN, Christine | TCHELEBI, Leila T. | NEWPORT, Kristina B. | FOX, Edward J. | WANG, Ming-Shang

BACKGROUND: We propose a predictive model that identifies patients at greatest risk of death after palliative radiotherapy, which can help medical professionals choose treatments that better align with patient choice and prognosis. METHODS: The National Cancer Database was queried for recipients of palliative radiotherapy during first course of treatment. Cox regression models and adjusted hazard ratios with 95% confidence intervals were used to evaluate survival predictors. The mortality risk index was calculated using predictors from the estimated Cox regression model, with higher values indicating higher mortality risk. Based on tertile cutpoints, patients were divided into low, medium, and high risk groups. RESULTS: A total of 68,505 patients were included from 2010-2014 (median age 65.7 years, standard deviation 11.8 years, IQR 16, median 66). Upon univariable and multivariable analyses, several risk factors were found to predict survival: (1) location of metastases (liver, bone, lung, and brain); (2) age >65 years; (3) tumor primary (prostate, breast, and lung); (4) male; (5) Charlson-Deyo comorbidity score of 3+; and (6) radiotherapy site, including bone, brain and eye, thorax, and stomach, liver, pancreas, kidney, and abdomen. The median survival times were 11.66 months, 5.09 months, and 3.28 months in the low (n=22,621), medium (n=22,638), and high risk groups (n=22,611), respectively. A nomogram was created and validated to predict survival, available online, https://tinyurl.com/METSSSmodel. CONCLUSION: We created a predictive nomogram for survival of patients receiving palliative radiotherapy during their first course of treatment (named METSSS), based on Metastases location, Elderly (>65 years), Tumor primary, Sex, Sickness/comorbidity, and Site of radiotherapy.

http://dx.doi.org/10.1016/j.radonc.2021.02.011

Voir la revue «Radiotherapy and oncology, 158»

Autres numéros de la revue «Radiotherapy and oncology»

Consulter en ligne

Suggestions

Du même auteur

Survival after palliative radiation therapy f...

Article indépendant | ZAORSKY, Nicholas G. | Radiotherapy and oncology | vol.158

BACKGROUND: We propose a predictive model that identifies patients at greatest risk of death after palliative radiotherapy, which can help medical professionals choose treatments that better align with patient choice and prognosis...

Validation of the Brief Pain Inventory in a T...

Article indépendant | GER, Luo-Ping | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | n°5 | vol.18

Validation of the Brief Pain Inventory in a T...

Article indépendant | GER, Luo-Ping | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | n°5 | vol.18

De la même série

Survival after palliative radiation therapy f...

Article | ZAORSKY, Nicholas G. | Radiotherapy and oncology | vol.158

BACKGROUND: We propose a predictive model that identifies patients at greatest risk of death after palliative radiotherapy, which can help medical professionals choose treatments that better align with patient choice and prognosis...

Randomized phase II trial evaluating pain res...

Article | SPRAVE, Tanja | Radiotherapy and oncology | n°2 | vol.128

Background: To report the primary endpoint of a randomized trial comparing pain response following palliative stereotactic body radiation therapy (SBRT) versus conventionally-fractionated 3D-conformal radiotherapy (3DCRT) for prev...

Palliative radiation therapy in the last 30 d...

Article | PARK, Kyung Ran | Radiotherapy and oncology | n°2 | vol.125

Purpose: To investigate the utilization of palliative radiation therapy (RT), predictors for the use of RT, and symptom palliation following RT during the last 30 days of life through systemic review of literature. Materials/metho...

The use of patient reported outcome measures ...

Article | OLDENBURGER, E. | Radiotherapy and oncology | vol.49

Radiotherapy (RT) can be used to palliate cancer-related symptoms and improve quality of life (QoL). Patient Reported Outcome Measures (PROMs) could be a reliable, minimally invasive method to monitor patients after palliative rad...

Single vs multiple fraction palliative radiat...

Article | CHOW, Ronald | Radiotherapy and oncology

INTRODUCTION: There has been a long-standing debate regarding the efficacy of single fraction radiotherapy (SFRT) compared to multiple fraction radiotherapy (MFRT); many systematic reviews and meta-analyses have been conducted to ...

Chargement des enrichissements...